Levosimendan In Ambulatory Heart Failure Patients

Clinical trial NCT04705337 · TERMINATED

Trial details

NCT number: NCT04705337
Sponsor: Medical University of Bialystok
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Heart Failure New York Heart Association Class III Heart Failure New York Heart Association Class IV Heart Failure, Systolic Heart Failure With Reduced Ejection Fraction

Start date: 2021-12-15
Primary completion: 2024-02-29
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.